BioSpace News Archive

INmune Bio, Inc. announced that Raymond J. Tesi, MD, President and CEO, will present at the BIO CEO & Investor Conference being held February 14 – 17 at the Marriott Marquis in New York City.

The American Urological Association’s Urology Scientific Mentoring and Research Training Academy is pleased to announce the 2022 cohort of mentees.

Evofem Biosciences, Inc., (NASDAQ: EVFM) will present at the Aegis Virtual Conference.

Neuromagen Pharma Ltd., a company developing a new class of telomerase-targeting drugs for the treatment of degenerative, and senescence-associated diseases will provide a company overview at the sixteenth annual BIO-Europe Spring® partnering conference which will be held March 28-31, 2022 in a fully digital format.

YPrime, LLC, announced today the strategic acquisition of Tryl, a software development company with a unique patient engagement solution that brings together beautiful design, dynamic personalization, and applied behavioral science that is designed to boost engagement, reduce dropouts, and deliver outcomes in clinical trials.

International medical imaging IT and cybersecurity company Sectra announces that its radiology module for enterprise imaging, Sectra PACS, has won the prestigious customer satisfaction award Best in KLAS.

For the sixth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry.

n-Lorem, a nonprofit foundation , is collaborating with Cytiva in support of n-Lorem’s effort to discover and provide experimental antisense oligonucleotide (ASO) medicines to nano-rare disease patients.

Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced the Bioptx™ platform of biomarker sensing products and solutions for the medical and healthcare market.

Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that it has entered into a data sharing agreement with Pfizer, a leader in innovative IBD research.